Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Laird Forrest

Showing results (41-50 of 102) with videos related to

Pageof 11
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 24, 2006
Lipophilic prodrugs of Hsp90 inhibitor geldanamycin for nanoencapsulation in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micellesM Laird Forrest, Anni Zhao, Chee-Youb Won, et al.
Applied Spectroscopy|August 17, 2016
Development and Validation of an Inductively Coupled Plasma Mass Spectrometry (ICP-MS) Method for Quantitative Analysis of Platinum in Plasma, Urine, and TissuesTi Zhang, Shuang Cai, Wai Chee Forrest, et al.
Journal of Pharmaceutical Sciences|June 20, 2019
Effect of Iron Oxide Nanoparticles on the Oxidation and Secondary Structure of Growth HormoneNinad Varkhede, Björn-Hendrik Peters, Yangjie Wei, et al.
Molecular Pharmaceutics|October 25, 2022
Glatiramer Acetate Complexed with CpG as Intratumoral Immunotherapy in Combination with Anti-PD-1Aric Huang, Chad Groer, Ruolin Lu, et al.
Molecular Cancer Research : MCR|March 17, 2018
Olaparib-induced Adaptive Response Is Disrupted by FOXM1 Targeting that Enhances Sensitivity to PARP InhibitionPingping Fang, Jill A Madden, Lisa Neums, et al.
American Journal of Surgery|October 11, 2011
Subcutaneous delivery of nanoconjugated doxorubicin and cisplatin for locally advanced breast cancer demonstrates improved efficacy and decreased toxicity at lower doses than standard systemic combination therapy in vivoStephanie M Cohen, Ridhwi Mukerji, Shuang Cai, et al.
Journal of Pharmaceutical Sciences|December 3, 2014
Routes of administration and dose optimization of soluble antigen arrays in mice with experimental autoimmune encephalomyelitisSharadvi Thati, Christopher Kuehl, Brittany Hartwell, et al.
Analytical Biochemistry|October 22, 2021
Analysis of N<sup>15</sup>-rat growth hormone after incubation with rat subcutaneous tissue and immune cells using ultra-pressure chromatography-mass spectrometryNinad Varkhede, Peters Björn-Hendrik, K Ryan Moulder, et al.
Photodiagnosis and Photodynamic Therapy|December 26, 2021
Hyaluronic acid carrier-based photodynamic therapy for head and neck squamous cell carcinomaTi Zhang, Moustafa M Abdelaziz, Shuang Cai, et al.
Therapeutic Delivery|August 13, 2011
Flip-flop pharmacokinetics--delivering a reversal of disposition: challenges and opportunities during drug developmentJaime A Yáñez, Connie M Remsberg, Casey L Sayre, et al.
Pageof 11

Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 24, 2006
Lipophilic prodrugs of Hsp90 inhibitor geldanamycin for nanoencapsulation in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micellesM Laird Forrest, Anni Zhao, Chee-Youb Won, et al.
Applied Spectroscopy|August 17, 2016
Development and Validation of an Inductively Coupled Plasma Mass Spectrometry (ICP-MS) Method for Quantitative Analysis of Platinum in Plasma, Urine, and TissuesTi Zhang, Shuang Cai, Wai Chee Forrest, et al.
Journal of Pharmaceutical Sciences|June 20, 2019
Effect of Iron Oxide Nanoparticles on the Oxidation and Secondary Structure of Growth HormoneNinad Varkhede, Björn-Hendrik Peters, Yangjie Wei, et al.
Molecular Pharmaceutics|October 25, 2022
Glatiramer Acetate Complexed with CpG as Intratumoral Immunotherapy in Combination with Anti-PD-1Aric Huang, Chad Groer, Ruolin Lu, et al.
Molecular Cancer Research : MCR|March 17, 2018
Olaparib-induced Adaptive Response Is Disrupted by FOXM1 Targeting that Enhances Sensitivity to PARP InhibitionPingping Fang, Jill A Madden, Lisa Neums, et al.
American Journal of Surgery|October 11, 2011
Subcutaneous delivery of nanoconjugated doxorubicin and cisplatin for locally advanced breast cancer demonstrates improved efficacy and decreased toxicity at lower doses than standard systemic combination therapy in vivoStephanie M Cohen, Ridhwi Mukerji, Shuang Cai, et al.
Journal of Pharmaceutical Sciences|December 3, 2014
Routes of administration and dose optimization of soluble antigen arrays in mice with experimental autoimmune encephalomyelitisSharadvi Thati, Christopher Kuehl, Brittany Hartwell, et al.
Analytical Biochemistry|October 22, 2021
Analysis of N<sup>15</sup>-rat growth hormone after incubation with rat subcutaneous tissue and immune cells using ultra-pressure chromatography-mass spectrometryNinad Varkhede, Peters Björn-Hendrik, K Ryan Moulder, et al.
Photodiagnosis and Photodynamic Therapy|December 26, 2021
Hyaluronic acid carrier-based photodynamic therapy for head and neck squamous cell carcinomaTi Zhang, Moustafa M Abdelaziz, Shuang Cai, et al.
Therapeutic Delivery|August 13, 2011
Flip-flop pharmacokinetics--delivering a reversal of disposition: challenges and opportunities during drug developmentJaime A Yáñez, Connie M Remsberg, Casey L Sayre, et al.
Pageof 11